Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Prepaid Assets (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Prepaid Assets data on record, last reported at $36.2 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 11.71% year-over-year to $36.2 million; the TTM value through Sep 2025 reached $36.2 million, up 11.71%, while the annual FY2024 figure was $30.4 million, 100.03% up from the prior year.
  • Prepaid Assets reached $36.2 million in Q3 2025 per COLL's latest filing, down from $56.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $56.0 million in Q2 2025 and bottomed at $3.6 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $19.3 million, with a median of $15.2 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: fell 20.3% in 2021, then surged 203.19% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $5.9 million in 2021, then decreased by 4.51% to $5.6 million in 2022, then skyrocketed by 170.66% to $15.2 million in 2023, then soared by 100.03% to $30.4 million in 2024, then increased by 18.96% to $36.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $36.2 million in Q3 2025, $56.0 million in Q2 2025, and $44.0 million in Q1 2025.